Bilous M - Search Results

1

Can the response to interferon treatment be predicted in patients with chronic active hepatitis C?

Lin R, Schoeman MN, Craig PI, Bilous M, Grierson J, McDonald JA, Batey RG, Farrell GC. Lin R, et al. Among authors: bilous m. Aust N Z J Med. 1991 Jun;21(3):387-92. doi: 10.1111/j.1445-5994.1991.tb04715.x. Aust N Z J Med. 1991. PMID: 1953524 Clinical Trial.

2

Chronic non-A, non-B hepatitis: lack of correlation between biochemical and morphological activity, and effects of immunosuppressive therapy on disease progression.

Schoeman MN, Liddle C, Bilous M, Grierson J, Craig PI, Batey RG, Farrell GC. Schoeman MN, et al. Among authors: bilous m. Aust N Z J Med. 1990 Feb;20(1):56-62. doi: 10.1111/j.1445-5994.1990.tb00372.x. Aust N Z J Med. 1990. PMID: 2108661

3

Randomised controlled trial of recombinant human interferon -alpha A for chronic active hepatitis B.

Williams SJ, Craig PI, Cooksley WG, Bye WA, Bilous M, Grierson JM, Nightingale BN, Burnett L, Hensley WJ, Batey RG, et al. Williams SJ, et al. Among authors: bilous m. Aust N Z J Med. 1990 Feb;20(1):9-19. doi: 10.1111/j.1445-5994.1990.tb00362.x. Aust N Z J Med. 1990. PMID: 2181991 Clinical Trial.

4

Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment.

Weltman MD, Brotodihardjo A, Crewe EB, Farrell GC, Bilous M, Grierson JM, Liddle C. Weltman MD, et al. Among authors: bilous m. J Viral Hepat. 1995;2(1):39-45. doi: 10.1111/j.1365-2893.1995.tb00070.x. J Viral Hepat. 1995. PMID: 7493293 Clinical Trial.

5

Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.

Hope RL, Weltman M, Dingley J, Fiatarone J, Hope AH, Craig PI, Grierson JM, Bilous M, Williams SJ, Farrell GC. Hope RL, et al. Among authors: bilous m. Med J Aust. 1995 Jan 2;162(1):8-11. Med J Aust. 1995. PMID: 7845310 Clinical Trial.

6

Altered hepatic calcium homeostasis in guinea pigs with halothane-induced hepatotoxicity.

Farrell GC, Mahoney J, Bilous M, Frost L. Farrell GC, et al. Among authors: bilous m. J Pharmacol Exp Ther. 1988 Nov;247(2):751-6. J Pharmacol Exp Ther. 1988. PMID: 3183968

7

Conservative surgery and radiation therapy for invasive lobular carcinoma of the breast.

Francis M, Cakir B, Bilous M, Ung O, Boyages J. Francis M, et al. Among authors: bilous m. Aust N Z J Surg. 1999 Jun;69(6):450-4. doi: 10.1046/j.1440-1622.1999.01596.x. Aust N Z J Surg. 1999. PMID: 10392891

8

Prognostic significance of c-erbB-2 oncogene in axillary node-negative breast cancer.

Molland JG, Barraclough BH, Gebski V, Milliken J, Bilous M. Molland JG, et al. Among authors: bilous m. Aust N Z J Surg. 1996 Feb;66(2):64-70. doi: 10.1111/j.1445-2197.1996.tb01113.x. Aust N Z J Surg. 1996. PMID: 8602816

9

Ductal carcinoma in situ. Part 2: Treatment.

Delaney G, Ung O, Cahill S, Bilous M, Boyages J. Delaney G, et al. Among authors: bilous m. Aust N Z J Surg. 1997 Apr;67(4):157-65. doi: 10.1111/j.1445-2197.1997.tb01931.x. Aust N Z J Surg. 1997. PMID: 9137153 Review.

10

Ductal carcinoma in situ. Part I: Definition and diagnosis.

Delaney G, Ung O, Bilous M, Cahill S, Greenberg M, Boyages J. Delaney G, et al. Among authors: bilous m. Aust N Z J Surg. 1997 Feb-Mar;67(2-3):81-93. doi: 10.1111/j.1445-2197.1997.tb01909.x. Aust N Z J Surg. 1997. PMID: 9068547 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters